Elevated B-Type Natriuretic Peptide Is Associated With Increased In-Hospital Mortality or Cardiac Arrest in Patients Undergoing Implantable Cardioverter-Defibrillator Implantation.

Autor:	Shaokui Wei, Loyo-Berríos, Nilsa I., Haigney, Mark C. P., Hong Cheng, Pinnow, Ellen E., Mitchell, Kristi R., Beachy, James H., Woodward, Albert M., Yongfei Wang, Curtis, Jeptha P., Marinac-Dabic, Danica
Předmět:	ATRIAL natriuretic peptides CARDIAC arrest IMPLANTABLE cardioverter-defibrillators IMPLANTED cardiovascular instruments KIDNEY diseases PATIENTS
Zdroj:	Circulation: Cardiovascular Quality & Outcomes; May2011, Vol. 4 Issue 3, p346-354, 9p, 3 Charts, 5 Graphs
Abstrakt:	The article discusses a study that examined the association between elevated B-type natriuretic peptide (BNP) level with increased risk of in-hospital mortality or cardiac arrest in patients undergoing implantable cardioverter-defibrillator (ICD). Findings found an increase in the rate of in-hospital mortality or cardiac arrest with elevated BNP level. It also showed that the association was more significant in men, renal dysfunction patients, and those undergoing biventricular ICD implantation.
Databáze:	Supplemental Index
Externí odkaz:	Zobrazit plný text záznamu